1. Home
  2. SMSI vs PASG Comparison

SMSI vs PASG Comparison

Compare SMSI & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith Micro Software Inc.

SMSI

Smith Micro Software Inc.

HOLD

Current Price

$2.67

Market Cap

16.7M

Sector

Technology

ML Signal

HOLD

Logo Passage Bio Inc.

PASG

Passage Bio Inc.

HOLD

Current Price

$4.95

Market Cap

14.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMSI
PASG
Founded
1982
2017
Country
United States
United States
Employees
N/A
27
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.7M
14.8M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
SMSI
PASG
Price
$2.67
$4.95
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$14.00
AVG Volume (30 Days)
14.3K
25.7K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
62.94
N/A
EPS
N/A
N/A
Revenue
$17,363,000.00
N/A
Revenue This Year
$13.97
N/A
Revenue Next Year
$53.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$3.29
52 Week High
$6.13
$20.00

Technical Indicators

Market Signals
Indicator
SMSI
PASG
Relative Strength Index (RSI) 39.75 56.34
Support Level $2.66 $4.94
Resistance Level $3.03 $5.92
Average True Range (ATR) 0.12 0.24
MACD -0.03 0.02
Stochastic Oscillator 17.53 45.21

Price Performance

Historical Comparison
SMSI
PASG

About SMSI Smith Micro Software Inc.

Smith Micro Software Inc provides software solutions that simplify and enhance the mobile experience to some of the wireless service providers around the globe. The company's solutions include SafePath product suite provides comprehensive and easy-to-use tools to protect family digital lifestyles and manage connected devices both inside and outside the home; CommSuite premium messaging platform helps mobile service providers deliver a next-generation voicemail experience to mobile subscribers, while monetizing a legacy cost-center; and ViewSpot its retail display management platform provided wireless carriers and retailers with a way to bring powerful on-screen, interactive demos to life. It operates in single segment: Wireless.

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Share on Social Networks: